Home

ERNEST A BATES

CIK 946042 · Chairman and CEO · last filed 2022-01-24

ERNEST A BATES is a Chairman and CEO who has filed 12 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for AMEH, was dated Jan 24, 2022. Across all open-market trades the lifetime net is −$39.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $922.6K across reported positions. 14 SEC filings were submitted jointly with SHARED HOSPITAL SERVICES AMERICAN.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$922.6K

Companies

2

Total Filings

12

Lifetime Open-Market Net

-$39.2K

Filer Profile

Reported Address
FOUR EMBARCADERO CENTER 3620
SAN FRANCISO, CA 94111-4155
State of Incorporation
CA
Related Filers
SHARED HOSPITAL SERVICES AMERICAN — 14 joint filings, latest 2017-03-31
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Astrana Health, Inc. (AMEH) Delisted Director — $40.82 — $0 5 2022-01-24
AMS Chairman and CEO 645,147 $1.43 $922.6K -$39.2K 7 2017-03-31

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-01-24 Astrana Health, Inc. (AMEH) Delisted Grant (A) — $0 EDGAR
2020-11-13 Astrana Health, Inc. (AMEH) Delisted Grant (A) — $0 EDGAR
2019-11-20 Astrana Health, Inc. (AMEH) Delisted Grant (A) — $0 EDGAR
2019-04-05 Astrana Health, Inc. (AMEH) Delisted Grant (A) — $0 EDGAR
2019-01-15 Astrana Health, Inc. (AMEH) Delisted Grant (A) — $0 EDGAR
2017-03-31 AMS Sell (S) −10,000 -$42.3K EDGAR
2017-01-06 AMS Grant (A) +66,177 $0 EDGAR
2016-06-10 AMS Buy (P) +500 $1.0K EDGAR
2016-06-08 AMS Buy (P) +1,000 $2.0K EDGAR
2015-01-27 AMS Grant (A) — $0 EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.